Go Pro

Lam Research Corporation $LRCX Shares Bought by IFP Advisors Inc

Lam Research logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • IFP Advisors increased its Lam Research stake by 24.8% in the second quarter to 21,044 shares valued at approximately $9.1 million. Institutional investors collectively own 84.61% of the company.
  • Lam Research reported quarterly earnings of $1.82 per share, beating estimates of $1.69, while revenue rose 30% year over year to $6.72 billion. Shares opened at $327.92, down 4.6%, and the company provided first-quarter fiscal 2027 EPS guidance of $2.00-$2.30.
  • Wall Street remains broadly positive, with 26 analysts rating the stock a Buy and a consensus “Moderate Buy” rating; the average price target is $358.47. However, company insiders sold 80,441 shares worth $27.6 million during the last quarter.
  • Five stocks to consider instead of Lam Research.

IFP Advisors Inc grew its stake in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 24.8% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 21,044 shares of the semiconductor company's stock after buying an additional 4,186 shares during the period. IFP Advisors Inc's holdings in Lam Research were worth $9,119,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Gateway Investment Advisers LLC raised its position in shares of Lam Research by 76.6% in the 2nd quarter. Gateway Investment Advisers LLC now owns 232,236 shares of the semiconductor company's stock worth $100,635,000 after buying an additional 100,745 shares during the period. Interchange Capital Partners LLC grew its position in Lam Research by 32.3% during the second quarter. Interchange Capital Partners LLC now owns 7,295 shares of the semiconductor company's stock valued at $3,161,000 after acquiring an additional 1,780 shares during the period. Market Street Wealth Management Advisors LLC acquired a new stake in Lam Research during the second quarter worth about $406,000. SlateStone Wealth LLC purchased a new position in shares of Lam Research in the 2nd quarter worth about $379,000. Finally, GFG Capital LLC purchased a new position in shares of Lam Research in the 2nd quarter worth about $213,000. 84.61% of the stock is owned by hedge funds and other institutional investors.

Lam Research Stock Down 4.6%

Shares of NASDAQ:LRCX opened at $327.92 on Wednesday. The company has a market capitalization of $410.33 billion, a price-to-earnings ratio of 56.93, a price-to-earnings-growth ratio of 1.32 and a beta of 1.84. The company has a 50 day moving average of $339.86 and a two-hundred day moving average of $284.93. Lam Research Corporation has a 52-week low of $94.11 and a 52-week high of $438.50. The company has a quick ratio of 1.91, a current ratio of 2.63 and a debt-to-equity ratio of 0.30.

Lam Research (NASDAQ:LRCX - Get Free Report) last posted its earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 EPS for the quarter, topping analysts' consensus estimates of $1.69 by $0.13. The business had revenue of $6.72 billion for the quarter, compared to analysts' expectations of $6.66 billion. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. The business's revenue for the quarter was up 30.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.33 earnings per share. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. As a group, analysts forecast that Lam Research Corporation will post 9.32 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Abhijit Y. Talwalkar sold 18,282 shares of Lam Research stock in a transaction dated Monday, July 13th. The stock was sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the sale, the director directly owned 87,142 shares of the company's stock, valued at approximately $29,192,570. The trade was a 17.34% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the business's stock in a transaction dated Thursday, June 11th. The stock was sold at an average price of $350.80, for a total value of $19,118,600.00. Following the completion of the transaction, the director owned 199,205 shares in the company, valued at approximately $69,881,114. This trade represents a 21.48% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 80,441 shares of company stock worth $27,614,296 in the last quarter. 0.31% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the company. Royal Bank Of Canada boosted their target price on Lam Research from $290.00 to $310.00 and gave the stock an "outperform" rating in a report on Thursday, April 23rd. Bank of America raised their price target on shares of Lam Research from $330.00 to $480.00 and gave the company a "buy" rating in a report on Tuesday, June 23rd. Morgan Stanley decreased their price objective on shares of Lam Research from $404.00 to $367.00 and set an "overweight" rating for the company in a research note on Thursday, July 30th. Raymond James Financial set a $425.00 price objective on shares of Lam Research in a research report on Wednesday, June 10th. Finally, Wall Street Zen downgraded shares of Lam Research from a "buy" rating to a "hold" rating in a research note on Sunday, May 10th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and five have given a Hold rating to the company's stock. According to MarketBeat.com, Lam Research has a consensus rating of "Moderate Buy" and a consensus target price of $358.47.

Read Our Latest Analysis on Lam Research

About Lam Research

(Free Report)

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Featured Stories

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Lam Research Right Now?

Before you consider Lam Research, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.

While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines